U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 11479

1.
CHALLENGES AND OPPORTUNITIES IN DRUG AND BIOMARKER DEVELOPMENT FOR NONALCOHOLIC STEATOHEPATITIS: FINDINGS AND RECOMMENDATIONS FROM AN AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES (AASLD) - FOOD AND DRUG ADMINISTRATION (FDA) JOINT WORKSHOP
Arun J. Sanyal, Scott L. Friedman, Arthur J. McCullough, Lara Dimick
Hepatology. Author manuscript; available in PMC 2016 Jun 9.
Published in final edited form as: Hepatology. 2015 Apr; 61(4): 1392–1405. Published online 2015 Mar 19. doi: 10.1002/hep.27678
PMCID:
PMC4900161
ArticlePDF–131K
2.
AGA Clinical Practice Update: Diagnosis and Management of Non-Alcoholic Fatty Liver Disease (NAFLD) in Lean Individuals: Expert Review
Michelle T. Long, Mazen Noureddin, Joseph K. Lim
Gastroenterology. Author manuscript; available in PMC 2023 Sep 1.
Published in final edited form as: Gastroenterology. 2022 Sep; 163(3): 764–774.e1. Published online 2022 Jul 14. doi: 10.1053/j.gastro.2022.06.023
PMCID:
PMC9398982
ArticlePDF–687K
3.
Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)
Associazione Italiana per lo Studio del Fegato (AISF), Società Italiana di Diabetologia (SID) and Società Italiana dell’Obesità (SIO)
Eat Weight Disord. 2022; 27(5): 1603–1619. Published online 2021 Dec 16. doi: 10.1007/s40519-021-01287-1
Correction in:
Eat Weight Disord. 2023; 28(1): 27.
PMCID:
PMC9123074
ArticlePDF–1.1M
4.
The Egyptian clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
Yasser Fouad, Gamal Esmat, Reda Elwakil, Serag Zakaria, Ayman Yosry, Imam Waked, Maissa El-Razky, Wahid Doss, Magdy El-Serafy, Ebraheem Mostafa, Mahmood Anees, Mohamed A. Sakr, Nadia AbdelAty, Ashraf Omar, Samy Zaki, Amgad Al-zahaby, Hamdy Mahfouz, Maysaa Abdalla, Mahmoud Albendary, Abdel-Khalek Hamed, Ahmed Gomaa, Adel Hasan, Sherif Abdel-baky, Medhat El sahhar, Gamal Shiha, Dina Attia, Ebada Saeed, Enas Kamal, Shamardan Bazeed, Mai Mehrez, Shereen Abdelaleem, Yasmine Gaber, Mohammed Abdallah, Asmaa Salama, Doaa A. Tawab, Shaymaa Nafady
Saudi J Gastroenterol. 2022 Jan-Feb; 28(1): 3–20. Published online 2022 Jan 25. doi: 10.4103/sjg.sjg_357_21
PMCID:
PMC8919931
ArticlePDF–1.5M
5.
Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease
Fasiha Kanwal, Jay H. Shubrook, Leon A. Adams, Kim Pfotenhauer, Vincent Wai-Sun Wong, Eugene Wright, Manal F. Abdelmalek, Stephen A. Harrison, Rohit Loomba, Christos S. Mantzoros, Elisabetta Bugianesi, Robert H. Eckel, Lee M. Kaplan, Hashem B. El-Serag, Kenneth Cusi
Gastroenterology. Author manuscript; available in PMC 2022 Sep 1.
Published in final edited form as: Gastroenterology. 2021 Nov; 161(5): 1657–1669. Published online 2021 Sep 20. doi: 10.1053/j.gastro.2021.07.049
PMCID:
PMC8819923
ArticlePDF–1.0M
6.
Quality Standards for the Management of NAFLD: Consensus Recommendations from the British Association for the Study of the Liver (BASL) and British Society of Gastroenterology (BSG) NAFLD Special Interest Group
Stuart McPherson, Matthew J Armstrong, Jeremy F. Cobbold, Lynsey Corless, Prof Quentin M Anstee, Richard J. Aspinall, Stephen T. Barclay, Paul N Brennan, Tessa M Cacciottolo, Prof Robert D Goldin, Kate Hallsworth, Vanessa Hebditch, Kathryn Jack, Helen Jarvis, Jill Johnson, Wenhao Li, Dina Mansour, Mary McCallum, Ashis Mukhopadhya, Richard Parker, Valerie Ross, Ian A Rowe, Ankur Srivastava, Prarthana Thiagarajan, Alexandra I. Thompson, Prof Jeremy Tomlinson, Prof Emmanuel A. Tsochatzis, Andrew Yeoman, Prof William Alazawi
Lancet Gastroenterol Hepatol. Author manuscript; available in PMC 2023 Aug 1.
Published in final edited form as: Lancet Gastroenterol Hepatol. 2022 Aug 1; 7(8): 755–769. Published online 2022 Apr 28. doi: 10.1016/S2468-1253(22)00061-9
PMCID:
PMC7614852
ArticlePDF–451K
7.
An explainable machine learning model for prediction of high-risk nonalcoholic steatohepatitis
Basile Njei, Eri Osta, Nelvis Njei, Yazan A. Al-Ajlouni, Joseph K. Lim
Sci Rep. 2024; 14: 8589. Published online 2024 Apr 13. doi: 10.1038/s41598-024-59183-4
PMCID:
PMC11016071
ArticlePDF–1.2M
8.
Innovative Molecular Targets and Therapeutic Approaches in Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (NAFLD/NASH) 3.0
Mariapia Vairetti, Giuseppe Colucci, Andrea Ferrigno
Int J Mol Sci. 2024 Apr; 25(7): 4010. Published online 2024 Apr 3. doi: 10.3390/ijms25074010
PMCID:
PMC11012541
ArticlePDF–168K
9.
Probiotic supplementation for 24 weeks in patients with non-alcoholic steatohepatitis: the PROBILIVER randomized clinical trial
Amanda Souza Silva-Sperb, Helena Abadie Moraes, Samantha Thifani Alrutz Barcelos, Bruna Concheski de Moura, Larisse Longo, Matheus Truccolo Michalczuk, Carlos Thadeu Schmidt Cerski, Carolina Uribe-Cruz, Themis Reverbel da Silveira, Mário Reis Álvares-da-Silva, Valesca Dall’Alba
Front Nutr. 2024; 11: 1362694. Published online 2024 Mar 27. doi: 10.3389/fnut.2024.1362694
PMCID:
PMC11004384
ArticlePDF–1.3M
10.
Validation of NIAAAm-CRP criteria to predict alcohol-associated steatohepatitis on liver histology
Rudolf E. Stauber, Pierre-Emmanuel Rautou, Horia Stefanescu, Adelina Horhat, Maja Thiele, Carolin Lackner, SALVE Histopathology Group
JHEP Rep. 2024 May; 6(5): 101055. Published online 2024 Mar 7. doi: 10.1016/j.jhepr.2024.101055
PMCID:
PMC11002864
ArticlePDF–514K
11.
Targeting hepatic ceruloplasmin mitigates nonalcoholic steatohepatitis by modulating bile acid metabolism
Quanxin Jiang, Ning Wang, Sijia Lu, Jie Xiong, Yanmei Yuan, Junli Liu, Suzhen Chen
J Mol Cell Biol. 2023 Sep; 15(9): mjad060. Published online 2023 Sep 28. doi: 10.1093/jmcb/mjad060
PMCID:
PMC10993722
ArticlePDF–2.0M
12.
Protective hepatocyte signals restrain liver fibrosis in metabolic dysfunction–associated steatohepatitis
Marcella Steffani, Yana Geng, Utpal B. Pajvani, Robert F. Schwabe
J Clin Invest. 2024 Apr 1; 134(7): e179710. Published online 2024 Apr 1. doi: 10.1172/JCI179710
PMCID:
PMC10977975
ArticlePDF–356K
13.
Piperine alleviates nonalcoholic steatohepatitis by inhibiting NF-κB-mediated hepatocyte pyroptosis
Suye Ran, Lingyu Song, Hong Yang, Jiangnan Yu, Yunhuan Zhen, Qi Liu
PLoS One. 2024; 19(3): e0301133. Published online 2024 Mar 28. doi: 10.1371/journal.pone.0301133
PMCID:
PMC10977780
ArticlePDF–2.2M
14.
Whole-Exome Sequencing (WES) Reveals Novel Sex-Specific Gene Variants in Non-Alcoholic Steatohepatitis (MASH)
Jing Wei, Boyang Jason Wu, Sayed S. Daoud
Genes (Basel) 2024 Mar; 15(3): 357. Published online 2024 Mar 13. doi: 10.3390/genes15030357
PMCID:
PMC10969913
ArticlePDF–2.7M
15.
Metabolic Dysfunction-Associated Steatohepatitis and Progression to Hepatocellular Carcinoma: A Literature Review
Haider Ghazanfar, Nismat Javed, Abeer Qasim, George Sarin Zacharia, Ali Ghazanfar, Abhilasha Jyala, Elona Shehi, Harish Patel
Cancers (Basel) 2024 Mar; 16(6): 1214. Published online 2024 Mar 20. doi: 10.3390/cancers16061214
PMCID:
PMC10969013
ArticlePDF–592K
16.
Roles of Traditional and Next-Generation Probiotics on Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Systematic Review and Network Meta-Analysis
Yuezhi Zhu, Jen Kit Tan, Jia Liu, Jo Aan Goon
Antioxidants (Basel) 2024 Mar; 13(3): 329. Published online 2024 Mar 7. doi: 10.3390/antiox13030329
PMCID:
PMC10968178
ArticlePDF–1.3M
17.
Double Trouble: How Microbiome Dysbiosis and Mitochondrial Dysfunction Drive Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
Wesam Bahitham, Siraj Alghamdi, Ibrahim Omer, Ali Alsudais, Ilana Hakeem, Arwa Alghamdi, Reema Abualnaja, Faisal M. Sanai, Alexandre S. Rosado, Consolato M. Sergi
Biomedicines. 2024 Mar; 12(3): 550. Published online 2024 Feb 29. doi: 10.3390/biomedicines12030550
PMCID:
PMC10967987
ArticlePDF–1.0M
18.
Oral Supplementation of Phosphatidylcholine Attenuates the Onset of a Diet-Induced Metabolic Dysfunction–Associated Steatohepatitis in Female C57BL/6J Mice
Victor Sánchez, Anja Baumann, Annette Brandt, Maximilian F. Wodak, Raphaela Staltner, Ina Bergheim
Cell Mol Gastroenterol Hepatol. 2024; 17(5): 785–800. Published online 2024 Jan 21. doi: 10.1016/j.jcmgh.2024.01.009
PMCID:
PMC10966192
ArticlePDF–2.9M
19.
A small molecule MST1/2 inhibitor accelerates murine liver regeneration with improved survival in models of steatohepatitis
Ryan Watkins, Ana Gamo, Seung Hyuk Choi, Manoj Kumar, EeeLN Buckarma, Chantal McCabe, Jennifer Tomlinson, David Pereya, Blaz Lupse, Shirin Geravandi, Nathan W Werneburg, Chen Wang, Patrick Starlinger, Siying Zhu, Sijia Li, Shan Yu, Murali Surakattula, Tyler Baguley, Amin Ardestani, Kathrin Maedler, Jason Roland, Van Nguyen-Tran, Sean Joseph, Mike Petrassi, Nikki Rogers, Gregory Gores, Arnab Chatterjee, Matthew Tremblay, Weijun Shen, Rory Smoot
PNAS Nexus. 2024 Mar; 3(3): pgae096. Published online 2024 Mar 1. doi: 10.1093/pnasnexus/pgae096
PMCID:
PMC10962727
ArticlePDF–865K
20.
Gentiopicroside improves non-alcoholic steatohepatitis by activating PPARα and suppressing HIF1
Chaoyuan Huang, Qiuhong Yong, Yihui Lu, Lu Wang, Yiyuan Zheng, Lina Zhao, Peiwu Li, Chong Peng, Wei Jia, Fengbin Liu
Front Pharmacol. 2024; 15: 1335814. Published online 2024 Mar 7. doi: 10.3389/fphar.2024.1335814
PMCID:
PMC10956515
ArticlePDF–4.2M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center